Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors

Norikazu Matsuo,Koichi Azuma,Kenta Murotani,Daiki Murata,Goushi Matama,Akihiko Kawahara,Takashi Kojima,Takaaki Tokito,Tomoaki Hoshino

Thoracic Cancer（2023）

引用 3|浏览19

暂无评分

摘要

In NSCLC patients, cachexia was associated with a worse prognosis, irrespective of tumor PD-L1 expression, indicating that cachexia is a predictive factor for NSCLC patients receiving immune checkpoint inhibitors.

查看译文

关键词

NSCLC,PD-1 inhibitor,cachexia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要